Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-01-10Clinical Trial Update: Genetic Mapping for Cardiac Risk Assessment
An ongoing genetic mapping trial intended to assess cardiac risk. The current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Prevalence of Sleep Disordered Breathing
A GE Healthcare-sponsored clinical trial evaluating the prevalence of sleep-disordered breathing in patients with unstable angina, acute myo…
-
FDA approval · 2011-12-23FDA Approved: HEPARIN SODIUM AND DEXTROSE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Heparin Sodium and Dextrose (Hospira, Inc.). The update concerns labeling/indications for this a…
-
CLINICAL_TRIALS trial_result · 2011-12-16Clinical Trial Update: Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluating atorvastatin (AtorVASTatin) for preventing vascular inflammatory occlusion in critically ill pa…
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: Noninvasive Ventilation in Acute Myocardial Infarction [Phase 1]
Phase 1 trial update reporting completion of a study evaluating noninvasive ventilation in patients with acute myocardial infarction.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-11-28FDA Approved: ATENOLOL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for generic atenolol from Rising Pharma Holdings, Inc. under the ANDA.
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI [Phase 4]
This Phase 4 randomized trial investigates whether early discharge after trans-radial coronary stenting for acute myocardial infarction is f…
-
CLINICAL_TRIALS trial_result · 2011-11-16Clinical Trial Update: Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty [Phase 4]
Phase 4 study assessing early versus late abciximab administration during primary percutaneous coronary intervention in patients with myocar…
-
CLINICAL_TRIALS research · 2011-11-08Clinical Trial Update: Bioabsorbable Versus Durable Polymer Drug Eluting Stent (DES): a Meta-analysis
This meta-analysis compares bioabsorbable polymer drug-eluting stents with durable polymer drug-eluting stents. It analyzes outcomes such as…
-
CLINICAL_TRIALS trial_result · 2011-11-04Clinical Trial Update: Study of Oral PG-116800 Following a Heart Attack [Phase 2]
Phase 2 trial of oral PG-116800 in patients after a heart attack has completed and results were posted in 2011.
-
CLINICAL_TRIALS research · 2011-10-31Clinical Trial Update: Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study [Phase 4]
Phase 4 clinical trial update investigating whether transforming emergent stenting into a planned elective procedure can reduce infarct size…
-
CLINICAL_TRIALS research · 2011-10-27Clinical Trial Update: Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI [Phase 4]
A multicenter Phase 4 randomized 2x2 factorial trial comparing tirofiban vs abciximab and sirolimus-eluting stents vs bare-metal stents in a…
-
EMA withdrawal · 2011-10-26EMA Withdrawn: Clopidogrel Sandoz (clopidogrel) — Acino Pharma GmbH
The EMA indicates withdrawal of Clopidogrel Sandoz (clopidogrel) by Acino Pharma GmbH.
-
FDA approval · 2011-10-25FDA Approved: ATENOLOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Atenolol from Teva Pharmaceuticals USA, Inc. This action updates the regulatory status of the ge…
-
FDA approval · 2011-10-18FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for atenolol submitted by Aurobindo Pharma Limited, granting regulatory approval for the supplem…
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy
A completed clinical trial evaluated how the timing of T-Wave Alternans testing affects its prognostic accuracy in patients with acute myoca…
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: Safety and Tolerability of RNS60 Given by IV to Healthy Subjects [Phase 1]
Phase 1 safety and tolerability study of intravenous RNS60 in healthy subjects, with myocardial infarct listed as the condition; the trial s…
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: CMR in the Assessment of Patient With ACS in the Emergency Room [NA]
This clinical trial evaluating cardiac magnetic resonance imaging for assessing patients with acute coronary syndrome in the emergency depar…
-
FDA approval · 2011-09-13FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for Atenolol by Zydus Lifesciences Limited under an ANDA, authorizing an approved supplemental actio…
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction [Phase 2]
Phase 2 trial evaluating recombinant human erythropoietin effects on platelet function in patients with acute myocardial infarction; study c…
-
CLINICAL_TRIALS research · 2011-09-08Clinical Trial Update: Side Branch Predilatation Strategy in Coronary Bifurcation Lesion Stenting (SBPS) [Phase 4]
Phase 4 clinical trial update evaluating side branch predilatation strategy in coronary bifurcation lesion stenting (SBPS); status is curren…
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack] [Phase 2]
Phase 2 clinical trial update on KAI-9803 for ST-elevation myocardial infarction, assessing safety and efficacy; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack [Phase 1, Phase 2]
This clinical trial update summarizes safety findings from Phase 1/2 studies of KAI-9803 injected during angioplasty after a myocardial infa…
-
CLINICAL_TRIALS research · 2011-09-01Clinical Trial Update: Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease [NA]
Clinical trial update on monitoring and adjustment of medication therapy for patients with heart disease; the status and phase information a…
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Effect Evaluation of Early Exercise Training After Myocardial Infarction [Phase 2]
Phase 2 clinical trial evaluating early exercise training after myocardial infarction has completed enrollment and results are being reporte…